» Articles » PMID: 34681009

Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2021 Oct 23
PMID 34681009
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Methamphetamine (METH)-use disorder (MUD) is a very serious, potentially lethal, biopsychosocial disease. Exposure to METH causes long-term changes to brain regions involved in reward processing and motivation, leading vulnerable individuals to engage in pathological drug-seeking and drug-taking behavior that can remain a lifelong struggle. It is crucial to elucidate underlying mechanisms by which exposure to METH leads to molecular neuroadaptive changes at transcriptional and translational levels. Changes in gene expression are controlled by post-translational modifications via chromatin remodeling. This review article focuses on the brain-region specific combinatorial or distinct epigenetic modifications that lead to METH-induced changes in gene expression.

Citing Articles

An update: epigenetic mechanisms underlying methamphetamine addiction.

Liu M, Si Z Front Cell Dev Biol. 2024; 12:1494557.

PMID: 39650725 PMC: 11621221. DOI: 10.3389/fcell.2024.1494557.


Epigenome-wide association study on methamphetamine dependence.

Shirai T, Okazaki S, Tanifuji T, Otsuka I, Horai T, Mouri K Addict Biol. 2024; 29(3):e13383.

PMID: 38488760 PMC: 11061849. DOI: 10.1111/adb.13383.


Incubation of methamphetamine craving in punishment-resistant individuals is associated with activation of specific gene networks in the rat dorsal striatum.

Daiwile A, McCoy M, Ladenheim B, Subramaniam J, Cadet J Mol Psychiatry. 2024; 29(7):1990-2000.

PMID: 38351172 PMC: 11408252. DOI: 10.1038/s41380-024-02455-2.


Are We Getting High Cause the Thrill is Gone?.

Blum K, Mclaughlin T, Gold M, Gondre-Lewis M, Thanos P, Elman I J Addict Psychiatry. 2024; 7(1):5-516.

PMID: 38164471 PMC: 10758019.


Methamphetamine-induced region-specific transcriptomic and epigenetic changes in the brain of male rats.

Miao B, Xing X, Bazylianska V, Madden P, Moszczynska A, Zhang B Commun Biol. 2023; 6(1):991.

PMID: 37758941 PMC: 10533900. DOI: 10.1038/s42003-023-05355-3.


References
1.
Kim B, Jha S, Seo J, Jeong C, Lee S, Lee S . MeBib Suppressed Methamphetamine Self-Administration Response via Inhibition of BDNF/ERK/CREB Signal Pathway in the Hippocampus. Biomol Ther (Seoul). 2020; 28(6):519-526. PMC: 7585641. DOI: 10.4062/biomolther.2020.041. View

2.
Wu H, Zhang Y . Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011; 25(23):2436-52. PMC: 3243055. DOI: 10.1101/gad.179184.111. View

3.
Yuka K, Nishizawa D, Hasegawa J, Uno K, Miyanishi H, Ujike H . A Single Medical Marker for Diagnosis of Methamphetamine Addiction - DNA Methylation of SHATI/NAT8L Promoter Sites from Patient Blood. Curr Pharm Des. 2020; 26(2):260-264. DOI: 10.2174/1381612826666200110111703. View

4.
Kaas G, Zhong C, Eason D, Ross D, Vachhani R, Ming G . TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron. 2013; 79(6):1086-93. PMC: 3816951. DOI: 10.1016/j.neuron.2013.08.032. View

5.
Ikegami D, Narita M, Imai S, Miyashita K, Tamura R, Narita M . Epigenetic modulation at the CCR2 gene correlates with the maintenance of behavioral sensitization to methamphetamine. Addict Biol. 2010; 15(3):358-61. DOI: 10.1111/j.1369-1600.2010.00219.x. View